Home Healthcare Healthcare Services Clinical Trial Logistics Market

Clinical Trial Logistics Market Size, Share & Trends Analysis Report By Service (Transportation, Warehousing & Distribution, Value-Added Services (Labelling, Kitting, QP Release)), By Clinical Phase (Phase I, Phase II, Phase III, Phase IV / post-marketing), By Therapeutic Area (Oncology, Cardiovascular Diseases, Rare / Orphan Diseases, Immunology & Inflammation, Endocrine & Metabolic Disorders, Neurology & Psychiatry, Others), By End-user (Bio-Pharma Manufacturers, CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations), Hospitals & Clinical-Trial Sites, Other End Users), By Temperature Range (Cold Chain) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 09, 2025 | Author: Debashree B | Format: | Report Code: SR7499DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Clinical Trial Logistics Market, By Service 2022-2034 (USD MILLION/ Units)
    1. Transportation
      1. Road
      2. Air
      3. Others
    2. Warehousing & Distribution
    3. Value-Added Services (Labelling, Kitting, QP Release)
  2. Clinical Trial Logistics Market, By Clinical Phase 2022-2034 (USD MILLION/ Units)
    1. Phase I
    2. Phase II
    3. Phase III
    4. Phase IV / post-marketing
  3. Clinical Trial Logistics Market, By Therapeutic Area 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Cardiovascular Diseases
    3. Rare / Orphan Diseases
    4. Immunology & Inflammation
    5. Endocrine & Metabolic Disorders
    6. Neurology & Psychiatry
    7. Others
  4. Clinical Trial Logistics Market, By End-user 2022-2034 (USD MILLION/ Units)
    1. Bio-Pharma Manufacturers
    2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
    3. Hospitals & Clinical-Trial Sites
    4. Other End Users
  5. Clinical Trial Logistics Market, By Temperature Range 2022-2034 (USD MILLION/ Units)
    1. Cold Chain
      1. Ambient (15-25 °C)
      2. Refrigerated (2–8 °C)
      3. Frozen (0 °C to -20 °C)
      4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
  6. Regional Clinical Trial Logistics Market
    1. North America
      1. North America Clinical Trial Logistics Market By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      2. North America Clinical Trial Logistics Market By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      3. North America Clinical Trial Logistics Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      4. North America Clinical Trial Logistics Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      5. North America Clinical Trial Logistics Market By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      6. U.S.
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      7. Canada
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    2. Europe
      1. Europe Clinical Trial Logistics Market By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      2. Europe Clinical Trial Logistics Market By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      3. Europe Clinical Trial Logistics Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      4. Europe Clinical Trial Logistics Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      5. Europe Clinical Trial Logistics Market By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      6. U.K.
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      7. Germany
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      8. France
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      9. Spain
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      10. Italy
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      11. Russia
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      12. Nordic
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      13. Benelux
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      14. Rest of Europe
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    3. APAC
      1. APAC Clinical Trial Logistics Market By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      2. APAC Clinical Trial Logistics Market By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      3. APAC Clinical Trial Logistics Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      4. APAC Clinical Trial Logistics Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      5. APAC Clinical Trial Logistics Market By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      6. China
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      7. Korea
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      8. Japan
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      9. India
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      10. Australia
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      11. Taiwan
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      12. South East Asia
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      13. Rest of Asia-Pacific
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    4. Middle East and Africa
      1. Middle East and Africa Clinical Trial Logistics Market By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      2. Middle East and Africa Clinical Trial Logistics Market By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      3. Middle East and Africa Clinical Trial Logistics Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      4. Middle East and Africa Clinical Trial Logistics Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      5. Middle East and Africa Clinical Trial Logistics Market By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      6. UAE
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      7. Turkey
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      8. Saudi Arabia
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      9. South Africa
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      10. Egypt
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      11. Nigeria
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      12. Rest of MEA
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
    5. LATAM
      1. LATAM Clinical Trial Logistics Market By Service 2022-2034 (USD MILLION/ Units)
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
      2. LATAM Clinical Trial Logistics Market By Clinical Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV / post-marketing
      3. LATAM Clinical Trial Logistics Market By Therapeutic Area 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiovascular Diseases
        3. Rare / Orphan Diseases
        4. Immunology & Inflammation
        5. Endocrine & Metabolic Disorders
        6. Neurology & Psychiatry
        7. Others
      4. LATAM Clinical Trial Logistics Market By End-user 2022-2034 (USD MILLION/ Units)
        1. Bio-Pharma Manufacturers
        2. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        3. Hospitals & Clinical-Trial Sites
        4. Other End Users
      5. LATAM Clinical Trial Logistics Market By Temperature Range 2022-2034 (USD MILLION/ Units)
        1. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      6. Brazil
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      7. Mexico
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      8. Argentina
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      9. Chile
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      10. Colombia
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
      11. Rest of LATAM
        1. Transportation
          1. Road
          2. Air
          3. Others
        2. Warehousing & Distribution
        3. Value-Added Services (Labelling, Kitting, QP Release)
        4. Phase I
        5. Phase II
        6. Phase III
        7. Phase IV / post-marketing
        8. Oncology
        9. Cardiovascular Diseases
        10. Rare / Orphan Diseases
        11. Immunology & Inflammation
        12. Endocrine & Metabolic Disorders
        13. Neurology & Psychiatry
        14. Others
        15. Bio-Pharma Manufacturers
        16. CROs (Contract Research Organizations) & CMOs (Contract Manufacturing Organizations)
        17. Hospitals & Clinical-Trial Sites
        18. Other End Users
        19. Cold Chain
          1. Ambient (15-25 °C)
          2. Refrigerated (2–8 °C)
          3. Frozen (0 °C to -20 °C)
          4. Ultra-Cold / Cryogenic (-20 °C to -150 °C)
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.